The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET: A randomized study of cessation of somatostatin analogues (SSA) after peptide receptor radionuclide therapy (PRRT) in mid, hind-gut, and pancreatic neuroendocrine tumours.
 
Matthew Burge
Stock and Other Ownership Interests - coclear; CSL Limited; Lilly; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
David Wyld
Research Funding - Ipsen (Inst)
 
David Pattison
No Relationships to Disclose
 
Sandra Bahamad
No Relationships to Disclose
 
Sarah Hayes
No Relationships to Disclose
 
Julia Kuszewski
No Relationships to Disclose
 
Lorraine Chantrill
Honoraria - Amgen; Amgen; Eisai; Merck; Pierre Fabre; SERVIER
Consulting or Advisory Role - BMS Australia; MSD Oncology
Research Funding - AstraZeneca (Inst)
 
Timothy Price
Honoraria - Amgen; Takeda
Consulting or Advisory Role - Amgen; MSD Oncology; SERVIER; Takeda
Research Funding - AMGEN (Inst)
(OPTIONAL) Uncompensated Relationships - Duo Oncology
 
Hui-Li Wong
Stock and Other Ownership Interests - Oncosil (I)
 
David Chan
No Relationships to Disclose
 
Piyush Grover
No Relationships to Disclose
 
Michael Michael
Honoraria - Astellas Pharma; Ipsen (Taiwan); Novartis; SAM NORDIC
Consulting or Advisory Role - Astellas Pharma; BeiGene (Australia); Ipsen; Isotopen Technologien; Merck; MSD; PanTher Therapeutics
Research Funding - Ipsen; Ipsen (Australia); Merck Serono
Travel, Accommodations, Expenses - Ipsen; Ipsen; Novartis
 
Derrick Siu
No Relationships to Disclose
 
Christine Bishop
No Relationships to Disclose
 
Daniel Barker
No Relationships to Disclose
 
Rachel Goodwin
Honoraria - Advanced Accelerator Applications; Eisai; Incyte; Incyte; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Apobiologix; Astellas Pharma; AstraZeneca Canada; Bayer; Eisai; Incyte; Ipsen; Merck; MSD; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical; Viatris
Speakers' Bureau - Amgen; Bayer; Bayer; Eisai; Ipsen; Merck; Mylan; Pfizer
Research Funding - Eisai; Ipsen
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Christopher O'Callaghan
No Relationships to Disclose
 
Jonathan Loree
Consulting or Advisory Role - Advanced Accelerator Applications; AMGEN; Bayer; Guardant Health; Ipsen; Merck; Roche; Taiho Pharmaceutical
Research Funding - Ipsen (Inst); Personalis
 
Weng John Mak
No Relationships to Disclose